Findings published in the Multiple Sclerosis Journal provide early validation of a process that could inform new clinical standards to improve attack diagnosis and treatment decision-making
. | June 12, 2023
Presentations will feature analyses from the pivotal Phase 3 study of UPLIZNA, including the relationship between B-cell subsets and NMOSD attacks Horizon Therapeutics plc (Nasdaq: HZNP) today
CANbridge Forms Scientific Advisory Board to Guide Global Development of CAN106 in Complement-mediated Diseases streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.